Ellipta gsk 101: trelegy ellipta fda approval?

Subscribers:
4,200
Published on ● Video Link: https://www.youtube.com/watch?v=02b97M8BbxE



Duration: 2:21
7 views
0


This vid helps get started w/ Ellipta gsk.

i. Trelegy Ellipta is a medication used for the treatment of chronic obstructive pulmonary disease (COPD). It is a combination inhaler containing three active ingredients: fluticasone furoate, umeclidinium, and vilanterol. Trelegy Ellipta received FDA approval in September 2017 for the long-term, once-daily maintenance treatment of patients with COPD, including chronic bronchitis and emphysema. However, for the most current and specific information, I recommend checking the FDA website or recent news updates.

Learn more:
(1) About Trelegy Ellipta - GSK. https://www.gsk.com/en-gb/media/press-releases/gsk-and-innoviva-report-positive-headline-results-from-impact-study-showing-single-inhaler-triple-therapy-trelegy-ellipta-reduced-copd-exacerbations/.
(2) GSK submits filing to FDA for Trelegy Ellipta use in patients with .... https://us.gsk.com/en-us/media/press-releases/gsk-submits-filing-to-fda-for-trelegy-ellipta-use-in-patients-with-asthma/.
(3) How to use the Ellipta inhaler - public.gsk.ie. https://public.gsk.ie/content/dam/global/hcpportal/en_IE/PDFs/ellipta/ellipta-how-to-tear-off-pad-apr-2023.pdf.